Clinical trial
The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in…
NCT00179400 · Albert Einstein College of Medicine, Other · Completed
Key facts
| NCT number | NCT00179400 |
|---|---|
| Title | The Role of Acute Combined PPAR Alpha and Gamma Stimulation on Insulin Action in Humans |
| Official title | The Role of Acute Combined Peroxisome Proliferator-Activated Receptors (PPAR) Alpha and Gamma Stimulation on Insulin Action in Humans |
| Lead sponsor | Albert Einstein College of Medicine, Other |
| Collaborators | Takeda Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug, Procedure |
| Interventions | Pioglitazone, Placebo, Pancreatic Clamp Study |
| Enrollment | 26 |
| Start date | Dec 1, 2000 |
| Primary completion | Jul 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Sep 16, 2005 |
| Last update posted | Mar 3, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: